Patent Issued for Method and system for treating central sleep apnea (USPTO 12102758).

A patent has been issued for a method and system to treat central sleep apnea, focusing on controlling breathing by maintaining specific levels of carbon dioxide in arterial blood. The patent aims to address sleep-disordered breathing syndromes, including central sleep apnea, by stabilizing respiration and establishing appropriate blood gas levels. The system involves a respiratory conduit with a control device to regulate the release of a controlled amount of exhaled carbon dioxide, providing a potential solution for individuals with central sleep apnea. [Extracted from the article]